Clinical trial
A Phase 1 Study of PNT2258 in Patients With Advanced Solid Tumors
NCT01191775 is registered in ClinicalTrials.gov with Sierra Oncology LLC - a GSK company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of PNT2258 in Patients With Advanced Solid Tumors
- Lead sponsor
- Sierra Oncology LLC - a GSK company
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- April 30, 2012
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.